Intervention study of continuous nursing on recurrent adverse cardiovascular events in patients after percutaneous coronary intervention

被引：0
|
作者：
Liu, Qiaoling [1 ]
Liu, Zhiping [1 ]
Wei, Tanwei [2 ,3 ]
机构：
[1] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Cardiovasc Med, Wuhan, Peoples R China
[2] Puren Hosp Wuhan, Dept Ophthalmol, Wuhan, Peoples R China
[3] Puren Hosp Wuhan, Dept Ophthalmol, 1 BenXi Rd, Wuhan 430080, Peoples R China
来源：
MINERVA SURGERY | 2023年 / 78卷 / 03期
关键词：
D O I：
10.23736/S2724-5691.21.09190-5
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：337 / 339
页数：3
相关论文
共 50 条
  • [31] A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
    Kong, Shuting
    Chen, Changxi
    Zheng, Gaoshu
    Yao, Hui
    Li, Junfeng
    Ye, Hong
    Wang, Xiaobo
    Qu, Xiang
    Zhou, Xiaodong
    Lu, Yucheng
    Zhou, Hao
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [32] A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
    Shuting Kong
    Changxi Chen
    Gaoshu Zheng
    Hui Yao
    Junfeng Li
    Hong Ye
    Xiaobo Wang
    Xiang Qu
    Xiaodong Zhou
    Yucheng Lu
    Hao Zhou
    BMC Cardiovascular Disorders, 21
  • [33] Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention
    Rutten, Bert
    Roest, Mark
    McClellan, Elizabeth A.
    Sels, Jan W.
    Stubbs, Andrew
    Jukema, J. Wouter
    Doevendans, Pieter A.
    Waltenberger, Johannes
    van Zonneveld, Anton-Jan
    Pasterkamp, Gerard
    de Groot, Philip G.
    Hoefer, Imo E.
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 353 - 360
  • [34] Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis
    Caturano, Alfredo
    Spiezia, Serenella
    Sasso, Ferdinando Carlo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 155 - 156
  • [35] Haptoglobin genotype is predictive of adverse clinical events after percutaneous coronary intervention in diabetic patients
    Levy, AP
    Roguin, A
    Koch, W
    Kastrati, A
    Schomig, A
    CIRCULATION, 2002, 106 (19) : 625 - 625
  • [36] Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Xiao, Zhibin
    Riletu, Aoge
    Yan, Xiaoyu
    Meng, Qi
    Zhang, Weiru
    Zhang, Na
    Ma, Chi
    Guo, Xin
    Han, Jiatong
    Nie, Huijuan
    Deng, Hui
    Liu, Jing
    Chen, Jianping
    Dong, Yu
    Liu, Tianlong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04) : 621 - 629
  • [37] Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention
    Shioji, Keisuke
    Moriwaki, Soji
    Takeuchi, Yuzo
    Uegaito, Takashi
    Mutsuo, Satoru
    Matsuda, Mitsuo
    CIRCULATION JOURNAL, 2007, 71 (05) : 675 - 680
  • [38] The influence of aging on cardiovascular events in patients with percutaneous coronary intervention.
    Cho, Y. X.
    Nam, C. W.
    Hur, S. H.
    Kim, K. B.
    Cho, H. O.
    Kim, H. S.
    Han, S. W.
    Kim, Y. N.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 81F - 81F
  • [39] Adverse Events Even after Percutaneous Coronary Intervention: Is There Any Way to Predict It?
    Setiadi, Benny Mulyanto
    Han, Lei
    Jing, Chang
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2010, 23 (01) : 86 - 94
  • [40] Shedding blood: anemia and adverse events after percutaneous coronary intervention (PCI)
    Galougahi, Keyvan Karimi
    Karmpaliotis, Dimitri
    Kirtane, Ajay J.
    Ali, Ziad A.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (03) : 303 - 306
12345